GRID2IP and neoplasm: The results showed that up-regulation of GRID2IP was related to worse clinical features, which includes T-stage, N-stage, M-stage, pathology stage, BMI, residual tumor, lymphatic invasion, CEA level, tumor status (Fig. 6A–I).